-
DISH: Univision Pulls Channels; Demands DISH Hispanic Customers Pay More Despite Ratings Decline; Fourth Major Univision-Driven Blackout in Two Years
 ENGLEWOOD, Colo., June 30, 2018 /PRNewswire/ -- In an effort to drastically raise rates amid declining viewership, today Univision Communications Inc. blocked DishLATINO and DISH customers from accessing three of its channels: Univision and UniMás (including local affiliates), and...
-
DISH: Univision Suspende Señal de Sus Canales; Exige que los Clientes Hispanos de DISH Paguen Más a Pesar de la Caída de Sintonía; La Tercera Suspensión que Hace Univision en los Últimos Dos Años
 ENGLEWOOD, Colorado, 30 de junio de 2018 /PRNewswire-HISPANIC PR WIRE/ -- En un esfuerzo por aumentar drásticamente las tarifas de transmisión en un momento de caída de sintonía, hoy Univision Communications, Inc. bloqueó a los clientes de DishLATINO y DISH de acceder tres canales:...
-
.au Completes Historic Transition to Afilias
 MELBOURNE, Australia, June 30, 2018 /PRNewswire/ -- auDA (.au Domain Administration Ltd) and Afilias Australia today announced the successful and historic transition of more than 3.1 million .au domain names from a legacy system to all new infrastructure in Australia. Prior to this event,...
-
South Korea Zoo Lions that killed Keeper relocated to Colorado Sanctuary.
 KEENESBURG, Colo., June 30, 2018 /PRNewswire-USNewswire/ -- Ending a nearly three and one-half year stand-off between South Korean zoo officials, a deceased man's family and the Korean Animal Welfare Society (KAWA), The Wild Animal Sanctuary in Colorado steps in to give three Lions slated...
-
JA Solar fournit des modules à demi-cellule pour une centrale solaire en Afrique
BEIJING, 30 juin 2018 /PRNewswire/ -- JA Solar Holdings Co., Ltd. (Nasdaq : JASO), principal fabricant mondial de produits d'énergie hélio-électrique à haut rendement, a annoncé ce jour avoir fourni des modules à demi-cellule de 6,5 MW pour une centrale solaire située en Namibie,...
-
Nurses Ratify Contract with the University of Cincinnati Medical Center
 CINCINNATI, June 30, 2018 /PRNewswire-USNewswire/ -- Members of the Registered Nurses Association, a local union of the Ohio Nurses Association, overwhelmingly ratified a three-year collective bargaining agreement with the University of Cincinnati Medical Center Saturday afternoon. The...
-
JA Solar fornisce moduli semi cella per un impianto solare in Africa
PECHINO, 30 giugno 2018 /PRNewswire/ -- JA Solar Holdings Co., Ltd. (Nasdaq: JASO), un produttore leader mondiale di prodotti per energia solare a elevate prestazioni, ha annunciato oggi di aver fornito moduli semi cella per un impianto solare da 6,5 MW in Namibia, Africa. Questo impianto...
-
LENDINGCLUB NOTICE: Rosen Law Firm Announces Securities Class Action Lawsuit Against LendingClub Corporation; Upcoming July 2 Deadline - LC
 NEW YORK, June 30, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of LendingClub Corporation (NYSE: LC) from February 28, 2015 through April 25, 2018, both dates inclusive...
-
MAN en Côte d'Ivoire : Lancement officiel de la distribution des véhicules et services après-vente par BIA
 ABIDJAN, Côte d'Ivoire, June 30, 2018 /PRNewswire/ --
Vendredi 29 juin 2018 : Inauguration en présence du Conseiller Technique du Ministre des Transports de Côte d'Ivoire, de l'ambassadeur d'Allemagne et du Premier Secrétaire de l'Ambassade du Royaume de Belgiq...
-
KT Corp. und GS Retail expandieren gemeinsames VR-Business VRIGHT
 Partner eröffnen zweiten VRIGHT Park in der Nähe der Konkuk Univ. im Osten von Seoul
Erster Park in Sinchon im Westen von Seoul zieht über 18.000 Besucher in vier Monaten an
KT plant, VR-Business nächstes Jahr in Südkorea und im Ausland als Franchise zu vergeben...
-
KT Corp. et GS Retail développent leurs activités RV conjointes « VRIGHT »
Les deux partenaires ouvrent un deuxième parc VRIGHT à proximité de l'Université Konkuk dans la partie est de Séoul
Le premier parc, situé à Sinchon, dans la partie ouest de Séoul, a attiré plus de 18 000 visiteurs en 4 mois
L'année prochaine, KT envisage de franchiser ses...
-
FlipNpik Announces ICO Presale 30% Bonus for Early Birds
 LONDON and SINGAPORE, June 30, 2018 /PRNewswire/ -- FlipNpik, the world's first-of-its-kind blockchain-based collaborative social media platform, with a mission to de-centralize and improve the world's local economies, has announced today that it is launching as planned its Initial Coin Of...
-
THEKEY Launches USD 20 Million Scientific Research Fund
 BEIJING, June 30, 2018 /PRNewswire/ -- In order to realize the full societal benefit of the invaluable social insurance data that is increasingly being aggregated from China's hundreds of millions of current and future healthcare patients, THEKEY, the Information Center of Ministry of...
-
7 Tips to Take Control of Your Summer Move
 PHOENIX, June 30, 2018 /PRNewswire/ -- Once the realtor places a sign in your yard, life changes. And when "for sale" officially becomes "sold," the stress meter can rise as the prospect of moving merges with reality.
Summer is prime moving season as families make their big...
-
Etsy to Expand its Community Across Central Europe
BROOKLYN, N.Y., June 30, 2018 /PRNewswire/ -- Etsy, Inc. (NASDAQ: ETSY), the global marketplace for unique and creative goods, announced today that it has entered into a referral agreement with DaWanda, a privately held Germany-based marketplace for gifts and handmade items. As part of...
-
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Deutsche Bank Aktiengesellschaft of Class Action Lawsuit and Upcoming Deadline - DB
 NEW YORK, June 30, 2018 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Deutsche Bank Aktiengesellschaft ("Deutsche Bank" or the "Company") (NYSE: DB) and certain of its officers. The class action, filed in United States District Court...
-
GCL schließt Phase I des neuen 50-MW-Energieprojekts in Oregon rechtzeitig ab
 ADAMS, Oregon, 30. Juni 2018 /PRNewswire/ -- GCL New Energy Inc. (GCL oder „das Unternehmen"), eine Tochtergesellschaft des im Bereich erneuerbare Energien weltweit führenden Energiekonzerns GCL Group, hat bekannt gegeben, dass der Baufortschritt für die Phase I ihres 50-MW-GCL...
-
Secoo X Edison Chen, delivering 'Emotionally Unavailable'
SHANGHAI, June 30, 2018 /PRNewswire/ -- The Asian's largest premium lifestyle platform, Secoo cooperated with Emotionally Unavailable (EU), a fashion brand operated by Edison Chen and KB Lee, to release several types of limited products including Patten Hoodie, Logo Tee and Daddy Cap....
-
Lancement des smartphones primés de Honor sur les marchés d'Amérique latine
 SHENZHEN, Chine, 30 juin 2018 /PRNewswire/ -- Honor, marque de smartphones en ligne leader axée sur la génération numérique, a annoncé aujourd'hui son entrée officielle sur le marché d'Amérique latine dans le cadre du plan d'expansion mondiale en cours de la société. Dans le cadre d'événem...
-
JA Solar dodá půlčlánkové moduly pro solární elektrárnu v Africe
PEKING, 30. června 2018 /PRNewswire/ -- Společnost JA Solar Holdings Co., Ltd. (Nasdaq: JASO), přední světový výrobce vysoce výkonných solárních produktů, dnes oznámila, že dodá půlčlánkové moduly o celkovém výkonu 6,5 MW pro solární elektrárnu v Namibii v Africe. Tato elektrárna je...
-
FDA approves a new ultrasound imaging agent
The U.S. Food and Drug Administration today approved Lumason (sulfur hexafluoride lipid microsphere) for patients whose ultrasound image of the heart (echocardiograms) are hard to see with ultrasound waves.
-
FDA approves first combination pill to treat hepatitis C
The U.S. Food and Drug Administration today approved Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus (HCV) genotype 1 infection.
-
FDA approves first drug-coated angioplasty balloon catheter to treat vascular disease
The U.S. Food and Drug Administration today approved the Lutonix 035 Drug Coated Balloon Percutaneous Transluminal Angioplasty Catheter (Lutonix DCB). This is the first drug-coated balloon used to re-open arteries in the thigh (superficial femoral arteries) and knee (popliteal arteries) when narrowed or blocked as a result of peripheral artery disease (PAD).
-
FDA approves Akynzeo for nausea and vomiting associated with cancer chemotherapy
The U.S. Food and Drug Administration today approved Akynzeo (netupitant and palonosetron) to treat nausea and vomiting in patients undergoing cancer chemotherapy.
-
FDA seeks permanent injunction against Pharmaceutical Innovations, Inc.
The U.S. Food and Drug Administration is seeking a permanent injunction to stop Pharmaceutical Innovations Inc., and its principal officer, Gilbert Buchalter, from manufacturing, marketing, selling, and distributing medical products until they come into compliance with all applicable FDA requirements.
-
The FDA takes steps to strengthen cybersecurity of medical devices
To strengthen the safety of medical devices, the U.S. Food and Drug Administration today finalized recommendations to manufacturers for managing cybersecurity risks to better protect patient health and information.
-
FDA awards grants to stimulate drug, device development for rare diseases
The U.S. Food and Drug Administration today announced it has awarded 15 grants totaling more than $19 million to boost the development of medical device, drug, and biological products for patients with rare diseases, with at least a quarter of the funding going to studies focused solely on pediatrics.
-
U.S. Marshals seize botanical substance kratom from southern California facility
U.S. Marshals at the request of the U.S. Food and Drug Administration today seized more than 25,000 pounds of raw kratom material worth more than $5 million from Rosefield Management, Inc. in Van Nuys, California.
-
NIH and FDA win top award for intellectual property licensing of meningitis vaccine
The National Institutes of Health and the U.S. Food and Drug Administration will receive a top national award for the year’s most outstanding intellectual property licensing deal, for technology transfer of a pioneering, low-cost meningitis vaccine launched in sub-Saharan Africa. The 2014 Deals of Distinction Award will be presented to the two federal agencies and their collaborators by the Licensing Executives Society at the society’s 50th annual meeting, Oct. 5-8 in San Francisco.
-
FDA clears glucose monitoring system for use in hospital critical care units
Today the U.S. Food and Drug Administration cleared a new indication for the Nova StatStrip Glucose Hospital Meter System, extending its use to critically ill patients who have been hospitalized. This is the first blood glucose monitoring system (BGMS) cleared by FDA for use in these patients.
-
FDA food safety challenge to spur new technologies for fighting foodborne illness
The U.S. Food and Drug Administration is asking for potential breakthrough ideas on how to find disease-causing organisms in food – especially Salmonella in fresh produce.
-
FDA allows marketing of the first test to identify five yeast pathogens directly from a blood sample
The U.S. Food and Drug Administration today allowed marketing in the U.S. of the first direct blood test for detection of five yeast pathogens that cause bloodstream infections: Candida albicans and/or Candida tropicalis, Candida parapsilosis, Candida glabrata and/or Candida krusei.
-
FDA releases updated proposals to improve food safety and help prevent foodborne illness in response to public comments
Based on extensive outreach and public comment, the U.S. Food and Drug Administration today proposed revisions to four proposed rules designed to help prevent food-borne illness. When finalized, the proposed rules will implement portions of the FDA Food Safety Modernization Act (FSMA), which aims to strengthen food safety by shifting the focus to preventing food safety problems rather than responding to problems after the fact.
-
FDA approves Trulicity to treat type 2 diabetes
The U.S. Food and Drug Administration today approved Trulicity (dulaglutide), a once-weekly subcutaneous injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes.
-
FDA approves Movantik for opioid-induced constipation
The U.S. Food and Drug Administration today approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with chronic non-cancer pain.
-
FDA approves weight-management drug Contrave
The U.S. Food and Drug Administration today approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity.
-
FDA reminds health care professionals and consumers not to use sterile products from Downing Labs/NuVision Pharmacy of Texas
The U.S. Food and Drug Administration is reminding health care professionals and consumers about safety concerns with all sterile-use drug products made and distributed by Downing Labs LLC, doing business as NuVision Pharmacy, in Dallas, Texas. Health care professionals should not use any NuVision/Downing Labs sterile products for their patients because the firm cannot ensure the safety or quality of these products. Administration of a non-sterile drug product may result in serious and potentially life-threatening infection or death.
-
FDA allows marketing of the first test to assess risk of developing acute kidney injury
Today the U.S. Food and Drug Administration allowed marketing of the NephroCheck test, a first-of-a-kind laboratory test to help determine if certain critically ill hospitalized patients are at risk of developing moderate to severe acute kidney injury (AKI) in the 12 hours following the administration of the test. Early knowledge that a patient is likely to develop AKI may prompt closer patient monitoring and help prevent permanent kidney damage or death.
-
U.S. Marshals seize drug products from Flawless Beauty
Various unapproved and improperly labeled drug products that were marketed, sold and distributed via the Internet by Flawless Beauty LLC, of Asbury Park, New Jersey, have been seized by U.S. Marshals at the request of the U.S. Food and Drug Administration and the U.S. Attorney for the District of New Jersey. These products, including injectable drug products, were marketed, sold and distributed to individuals, retail outlets, health spas and clinics.
-
FDA approves Keytruda for advanced melanoma
The U.S. Food and Drug Administration today granted accelerated approval to Keytruda (pembrolizumab) for treatment of patients with advanced or unresectable melanoma who are no longer responding to other drugs.
|
